Physician profile
Kunal Patel
NPI 1346484664
$11,617.30
in general payments reported to CMS, 2019-2025
19 companies · $2,488 in 2025
The $2,488 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $4,913 · 2021: $152 · 2022: $217 · 2023: $2,648 · 2024: $280 · 2025: $2,488.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,216 · Food and Beverage: $2,201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,216.00 |
| Food and Beverage | $2,200.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $5,078.90 | 2019-2024 | |
| Abbott Laboratories | $3,835.28 | 2023-2025 | Mitraclip, Triclip |
| Edwards Lifesciences Corporation | $473.42 | 2022-2025 | Evoque, Pascal |
| Penumbra, INC. | $426.51 | 2025 | Indigo System |
| Boston Scientific Corporation | $379.49 | 2020-2022 | |
| Pfizer INC. | $308.39 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $215.41 | 2019-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $190.16 | 2021-2025 | Camzyos, Eliquis |
| Shockwave Medical, INC | $170.06 | 2025 | |
| Heartflow, INC. | $126.96 | 2024 | |
| Esperion Therapeutics, INC. | $107.74 | 2020 | |
| Medtronic, INC. | $80.26 | 2023-2024 | Venaseal, Osteocool Rf Ablation System |
| Philips North America LLC | $47.50 | 2022-2025 | IV Other |
| Astrazeneca Pharmaceuticals LP | $46.69 | 2019 | |
| Abiomed | $44.95 | 2024 | Impella |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $36.56 | 2019-2020 | |
| Amgen INC. | $18.11 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.69 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.